IBIO, INC. financials

IBIO CIK 0001420720

Source: EDGAR filings · Built 2026-09-22T00:54:50Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Free Cash Flow -23.85M -15.62M -19.04M -36.38M -50.64M -35.31M
EBITDA -34.56M -18.10M -15.98M -28.54M -27.02M -30.35M
Working Capital 80.48M 3.62M 11.83M 4.15M 14.63M 97.95M
Net Debt -54.20M -5.07M -9.75M 12.77M 3.17M -44.68M
Gross Margin — — — — 115.02% 38.34%
Operating Margin -35141.00% -4650.50% -7392.89% — -1576.27% -1312.15%
Net Margin -33044.00% -4594.25% -11069.78% — -2670.01% -978.79%
Return on Equity (ROE) -38.55% -123.50% -116.80% -422.66% -79.24% -21.37%
Return on Assets (ROA) -33.34% -79.26% -86.68% -157.76% -50.60% -15.79%
Current Ratio 7.85× 1.59× 4.08× 1.19× 1.48× 15.74×
Debt-to-Equity 0.03× 0.24× 0.21× 1.11× 0.41× 0.30×
Effective Tax Rate 0.00% 0.00% — — — —
Cash Conversion Ratio 0.70× 0.83× 0.74× 0.47× 0.75× 1.30×
Accruals Ratio -0.10× -0.13× -0.22× -0.84× -0.13× 0.05×
SBC % of Revenue 1373.00% 382.50% 905.78% — 232.32% 66.89%
CapEx Coverage -36.80× -48.58× -38.49× -5.12× -2.85× -5.73×
Free Cash Flow Per Share $-0.23 $-1.49 $-4.97 $-59.45 $-5.81 $-4.51

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 100.00K 400.00K 225.00K 0 — —
Revenues — — — 0 1.88M 2.37M
Cost of Goods and Services Sold — — — — 216.00K 1.46M
Gross Profit — — — — 2.17M 909.00K
Research and Development Expense 19.64M 8.31M 5.18M 10.33M 9.83M 9.99M
Operating Expenses 35.24M 19.00M 16.86M 29.34M 31.58M 32.02M
Operating Income (Loss) -35.14M -18.60M -16.63M -29.34M -29.70M -31.11M
Income Tax Expense (Benefit) 0 0 0 0 0 0
Net Income (Loss) Attributable to Parent -33.04M -18.38M -24.91M -65.01M -50.30M -23.21M
Earnings Per Share, Basic $-0.32 $-1.75 $-6.50 $-106.19 $-5.78 $-3.00
Weighted Average Number of Shares Outstanding, Basic 104.06M 10.50M 3.83M 612,000 8.72M 7.83M
Earnings Per Share, Diluted $-0.32 $-1.75 $-6.50 $-106.19 $-5.78 $-3.00
Weighted Average Number of Shares Outstanding, Diluted 104.06M 10.50M 3.83M 612,000 8.72M 7.83M

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value 56.40M 8.58M 14.21M 4.30M 22.68M 77.40M
Assets, Current 92.22M 9.72M 15.67M 26.26M 45.07M 104.60M
Assets 99.11M 23.18M 28.73M 41.21M 99.41M 146.97M
Liabilities, Current 11.74M 6.11M 3.84M 22.11M 30.44M 6.64M
Liabilities 13.40M 8.30M 7.41M 25.83M 35.92M 38.40M
Stockholders' Equity Attributable to Parent 85.71M 14.88M 21.32M 15.38M 63.48M 108.58M
Common Stock, Shares, Outstanding 55.70M 19.35M 8.62M 1.02M 8.73M 8.71M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities -23.22M -15.30M -18.55M -30.44M -37.48M -30.06M
Payments to Acquire Property, Plant, and Equipment 578.00K 16.00K 210.00K 5.74M 7.33M 4.92M
Net Cash Provided by (Used in) Investing Activities -32.00M 742.00K 906.00K 7.01M -5.13M -26.48M
Net Cash Provided by (Used in) Financing Activities 103.05M 8.93M 24.49M 2.30M -6.13M 78.83M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (IBIO CIK 0001420720), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

INMB

INMUNE BIO INC.

SDOT

Sadot Group Inc.

BLIS

NAPC Defense, Inc.